|

Effectiveness of ECP Therapy in Stable Angina Pectoris Patients

RECRUITINGN/ASponsored by Universitas Padjadjaran
Actively Recruiting
PhaseN/A
SponsorUniversitas Padjadjaran
Started2023-07-01
Est. completion2024-12
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \>= 18 years old
* Diagnosed with stable angina pectoris
* Anatomic vessel disease (VD) lesion with 2VD/3VD
* Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.
* Not planned to urgent CABG
* Minimum optimal medical therapy within 2 weeks
* Able and willing to sign informed consent and comply with study procedures
* The patient lives in Bandung City and its neighborhood
* Retired patient; or not actively working during working hours; or willing to take the time to participate in research.

Exclusion Criteria:

* Congestive Heart Failure
* Chronic heart failure with Functional Class NYHA III - IV
* LVEF \<35%
* Unprotected left main stenosis \>50%
* Blood pressure \>180/110mmHg
* Acute coronary syndrome
* Acute Heart Failure
* Severe aorta regurgitation
* Malignant arrhythmia
* Atrial fibrillation
* Premature ventricular complex
* Peripheral occlusive artery disease
* Phlebitis
* Deep vein thrombosis
* Hemorrhagic diathesis
* Severe chronic kidney disease
* Aortic aneurysm
* Abdominal aneurysm
* Osteoarthritis
* Low back pain
* Pregnancy
* Registered as other clinical study participant

Conditions3

Angina PectorisCounterpulsationHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.